Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
Clinical trial NCT04043676 · UNKNOWN
Trial details
- NCT number
- NCT04043676
- Sponsor
- Fundación Teófilo Hernando, Spain
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2022-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.